MAP2 and neoplasm: A novel tumor stem cell niche (CD133 and CD44), a specific cellular environment at the brain invasion border (TNC and MAP2) and a novel role for pituitary stem cells in the pathogenesis of adaCP has been proposed [2, 8, 17, 25].